Posted on: Tuesday, May 8th 2012 at 12:00 pm Written By: Sayer Ji, Founder
From the perspective of conventional cancer treatment a diagnosis of multi-drug resistant cancer is equivalent to a death sentence. By the time such a diagnosis occurs, the patient’s body has been irreversibly damaged by chemotherapy and radiation, and an even more aggressive cancer has emerged to take the place of the original one.
Tragically, these treatments do not simply fail, but make the cancers more malignant. This fact is effectively concealed by the name multidrug resistant cancer which makes it seem as if the cancer was so exceptionally resistant and malignant that the normally effective drugs used to treat it just couldn’t do the job.
But wouldn’t it be more accurate to call this multi-drug failed cancer, putting the responsibility back on the medical establishment, as it should be, in recognition of the impotence, or worse,cancer-promoting nature of its treatment choices?
In other words, instead of blaming the treatment failure on the patient’s body – or a set of virulent gene mutations within their cancer – it is time we look more closely at why conventional chemotherapy and radiation-based treatments breed multidrug resistance within the cancer of patients, who ultimately succumb to the effects of the treatment and not the cancer they were originally diagnosed with.
Multidrug resistant cancer is the byproduct of cancer doctors (oncologists) throwing the chemical and radiological kitchen sink at the patient and not only failing to improve their condition, but significantly worsening it. How so? In order to understand how conventional treatment drives the cancer into greater malignancy, we must first understand what cancer is….
Tumors are actually highly organized assemblages of cells, which are surprisingly well-coordinated for cells that are supposed to be the result of strictly random mutation. They are capable of building their own blood supply (angiogenesis), are able to defend themselves by silencing cancer-suppression genes, secreting corrosive enzymes to move freely throughout the body, alter their metabolism to live in low oxygen and acidic environments, and know how to remove their own surface-receptor proteins to escape detection by white blood cells. In a previous article titled “Is Cancer An Ancient Survival Program Unmasked?” we delved deeper into this emerging view of cancer as an evolutionary throw-back and not a byproduct of strictly random mutation.
Because tumors are not simply the result of one or more mutated cells “going rogue” and producing exact clones of itself (multi-mutational and clonal hypotheses), but are a diverse group of cells having radically different phenotypal characteristics, chemotherapy and radiation will affect each cell type differently.
Tumors are composed of a wide range of cells, many of which are entirely benign.
The most deadly cell type within a tumor or blood cancer, known as cancer stem cells (CSCs),has the ability to give rise to all the cell types found within that cancer.
They are capable of dividing by mitosis to form either two stem cells (increasing the size of the stem population), or one daughter cell that goes on to differentiate into a variety of cell types, and one daughter cell that retains stem-cell properties.
This means CSCs are tumorigenic (tumor-forming) and should be the primary target of cancer treatment because they are capable of both initiating and sustaining cancer. They are also increasingly recognized to be the cause of relapse and metastasis following conventional treatment.
The existence of CSCs explains why conventional cancer treatment has completely missed the boat when it comes to targeting the root cause of tumors. One reason for this is because existing cancer treatments have mostly been developed in animal models where the goal is to shrink a tumor. Because mice are most often used and their life spans do not exceed two years, tumor relapse is very difficult, if not impossible to study.
The first round of chemotherapy never kills the entire tumor, but only a percentage. This phenomenon is called the fractional kill. The goal is to use repeated treatment cycles (usually six) to regress the tumor population down to zero, without killing the patient.
What normally occurs is that the treatment selectively kills the less harmful populations of cells (daughter cells), increasing the ratio of CSCs to benign and/or less malignant cells. This is not unlike what happens when antibiotics are used to treat certain infections. The drug may wipe out 99.9% of the target bacteria, but .1% have or develop resistance to the agent, enabling the .1% to come back even stronger with time.
The antibiotic, also, kills the other beneficial bacteria that help the body fight infection naturally, in the same way that chemotherapy kills the patient’s immune system (white blood cells and bone marrow), ultimately supporting the underlying conditions making disease recurrence more likely.
The reality is that the chemotherapy, even though it has reduced the tumor volume, by increasing the ratio of CSCs to benign daughter cells, has actually made the cancer more malignant.
Radiotherapy has also been shown to increase cancer stem cells in the prostate, ultimately resulting in cancer recurrence and worsened prognosis. Cancer stem cells may also explain why castration therapy often fails in prostate cancer treatment.
Natural compounds have been shown to exhibit three properties which make them suitable alternatives to conventional chemotherapy and radiotherapy:
The primary reason why these substances are not used in conventional treatment is because they are not patentable, nor profitable. Sadly, the criteria for drug selection are not safety, effectiveness, accessibility and affordability. If this were so, natural compounds would form an integral part of the standard of care in modern cancer treatment.
Research indicates that the following compounds (along with common dietary sources) have the ability to target CSCs:
Sayer Ji is founder of Greenmedinfo.com, on the Board of Governors for the National Health Federation, and Fearless Parent, Steering Committee Member of the Global GMO Free Coalition (GGFC), a reviewer at the International Journal of Human Nutrition and Functional Medicine.
Gehörlose Online-Dating-Sites wird anbieten eine Einladung area erfüllen neue Menschen und konstruieren Beziehungen mit behinderten und behinderten Individuen. Viele Singles Sie leben mit einer Behinderung – von Hörverlust bis hin zu Lähmungen â € “während versucht diese besondere Person .Zum Beispiel über 5 Prozent von Menschen auf der Erde leiden mit Deaktivieren von Hörverlust, basierend...
Per tutti che vogliono semplicemente prendi il loro particolare relazione gioco a un livello superiore, EliteSingles è felice introdurre la nostra collaborazione con certificato Clinica Sociale dipendente e amore coach, Hilary Silver. Finding a dating mentor esattamente who si adatta a te potrebbe essere un difficile procedura. C’è una serie di soluzioni sul mercato, piuttosto...
1login Xbet 1xbet Turkey Credible Bookmakers Do this by going to appleid.apple.com after which following the steps to create a new Apple account. Make certain you set the state to Cyprus as your nation. You’ll have to sign into your new Apple ID on your telephone if you obtained a popup error. You ought to...
1xbet Giriş Most online bookies today have to offer a decent quantity of bonus offers, and 1xBet doesn’t drop the ball there. They’ve notably received a concentrate on Esports offers, which is nice information for anybody in search of esports betting in Canada. There are some countries which have not given 1xBet the chance to...
Definition Of Ethereum Moreover, Binance hasn’t shut off the taps to Ethereum, making the argument of it clogging the community considerably moot. Some retailers have already begun accepting ether as a way of fee, and that quantity is more likely to grow as customers look for alternatives to credit cards and different payment strategies. In...